Thomson Reuters
    EN : JP : CN : KR : ES : PT   
 
 
 
Current Opinion in Investigational Drugs


 
Editor-in-Chief, Mike Williams, Northwest University Medical School, Chicago, USA commented on the journal:
"Current Opinion in Investigational Drugs provides a unique review forum for the discussion of current developments in a wide range of therapeutic areas."

FEATURES

Peer reviewed by an internationally renowned editorial board, this superb title delivers to you the most important coverage on developments in all the therapeutic areas:

  • Anti-infectives
  • Anti-inflammatory, immunologicals and biologicals
  • Cardiovascular and renal
  • Central and peripheral nervous system
  • Endocrine and metabolics
  • Oncological

The systematic approach of this journal ensures that you won't miss any recent developments related to your own area of research.

  • Six therapeutic categories are covered with each being featured in separate journal issues, and each therapeutic area being covered twice-yearly
  • Monthly alerting service highlighting the most recently published papers and patents in all therapeutic areas relevant to drug R&D
  • Provides the most complete and systematic coverage available
  • Well structured and clearly sectioned to highlight areas of interest for quick referencing




associated products  
 
  IDdb
SDdb
IDeals
 


 

Additional Information

Subscribe

Contact

Tracey Collins, Senior Editor
tracey.collins@thomson.com
Kirstie Pickett, Editor
kirstie.pickett@thomson.com

 
Disclaimer | Terms of Use
Privacy Policy | Copyright